BLSM · Company research
BlossomHill Therapeutics, Inc. Common Stock (BLSM): Financial Statements
Reported statement data with reporting periods and sources preserved.
RESEARCH CONTEXT
Understand the numbers
Reported statement data with reporting periods and sources preserved. Use period, currency, units and source fields when interpreting values.
8records availableHealthcare
Financial Statements data
Database-backed records only
| statement type | period type | fiscal period | period end | revenue | cost of revenue | gross profit | operating income | pretax income | net income |
|---|---|---|---|---|---|---|---|---|---|
| balance_sheet | quarterly | FY-2026-Q2 | Tue Jun 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time) | — | — | — | — | — | — |
| cash_flow | annual | FY-2026-Q2 | Tue Jun 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time) | — | — | — | — | — | — |
| income_statement | annual | FY-2026-Q2 | Tue Jun 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time) | 0 | 0 | 0 | -46777000 | 0 | -44766000 |
| income_statement | quarterly | FY-2026-Q2 | Tue Jun 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time) | 0 | 0 | 0 | -24670000 | 0 | -23758000 |
| balance_sheet | quarterly | FY-2025-Q4 | Wed Dec 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time) | — | — | — | — | — | — |
| cash_flow | annual | FY-2025-Q2 | Mon Jun 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) | — | — | — | — | — | — |
| income_statement | annual | FY-2025-Q2 | Mon Jun 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) | 0 | — | 0 | -25557000 | 0 | -23722000 |
| income_statement | quarterly | FY-2025-Q2 | Mon Jun 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) | 0 | — | 0 | -14103000 | 0 | -13244000 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.